|
|
||||||||
The Journal of Immunology, Vol 141, Issue 9 2943-2950, Copyright © 1988 by American Association of Immunologists
ARTICLES |
EK Main, DS Monos and LA Lampson
Children's Cancer Research Center, Children's Hospital, Philadelphia, PA.
Neuroblastoma cell lines can have very low MHC Ag expression. The cell lines are insensitive to allo-killing by primed CTL, but are sensitive to non-MHC-restricted cytotoxicity. IFN-gamma increased class I expression, but the cells remained insensitive to CTL. Susceptibility to nonrestricted effectors was preserved. Class I+ glioma cell lines behaved similarly. The CTL resistance was localized to the recognition phase. Neuroblastoma lines did not form conjugates with primed T cells, but were lysed if they were coupled to the effectors via lectins. The levels of class I expression, and resistance to CTL, were constant over a range of IFN doses. HLA-A,B,C structure and distribution were studied more intensively on one cell line, CHP-100. HLA-A2 and -A3 were present on greater than or equal to 99% of the cells, in a unimodal distribution. After IFN treatment, the levels were similar to B cell controls. In two-dimensional gel electrophoresis, the molecules co- migrated with those of B cell controls. The defect may thus be in accessory proteins that are necessary for T cell recognition or binding, rather than in the structure or distribution of the HLA-A,B,C proteins.
This article has been cited by other articles:
![]() |
R. F. Rousseau, A. E. Haight, C. Hirschmann-Jax, E. S. Yvon, D. R. Rill, Z. Mei, S. C. Smith, S. Inman, K. Cooper, P. Alcoser, et al. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma Blood, March 1, 2003; 101(5): 1718 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abendroth, A. Simmons, S. Efstathiou, and R. A. Pereira Infection with an H2 recombinant herpes simplex virus vector results in expression of MHC class I antigens on the surfaces of human neuroblastoma cells in vitro and mouse sensory neurons in vivo J. Gen. Virol., October 1, 2000; 81(10): 2375 - 2383. [Abstract] [Full Text] |
||||
![]() |
A. K. Sarkar and J. G. Nuchtern Lysis of MYCN-amplified Neuroblastoma Cells by MYCN Peptide-specific Cytotoxic T Lymphocytes Cancer Res., April 1, 2000; 60(7): 1908 - 1913. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |